$920,000 of ALLSTATE INSURANCE COMPANY lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"NFIP Reauthorization Housing and Urban Development (HUD) Disparate Impact Rule and impact on insurance HR1109Litigation Transparency Act of 2025 Third-party litigation funding disclosure legislation RAMP Act/Medicare Secondary Payer GSE Insurance Requirements SMART Act and issues related to design patent reform S336Disaster Mitigation and Tax Parity Act of 2025 HR1481Catastrophic Risk Transfer Act of 2025 Expiring TCJA tax provisions and reforms impacting the insurance industry S586Flood Insurance Affordability Tax Credit Act Third party litigation funding taxation HR1566 / S1379REPAIR Act Federal Communications Commission (FCC) rulemaking request of the FCC to identify all burdensome rules CFPB Data Brokers Rule and impact on insurance RAMP Act to simplify Medicare claims settlement Proposed legislation related to a national data privacy law Autonomous Vehicle legislation related to vehicle generated data Issues related to natural disaster preparedness, mitigation and resiliency Value and impact of NOAA weather data Value and impact of FEMA pre and post disaster mitigation programs HR1105Disaster Resiliency and Coverage Act of 2025 HR471Fix our Forests Resilient AMERICA Act focused on disaster and risk mitigation funding HR1981, S890Choice in Affordable Housing Act GSE Rules and Insurance Requirements"
You can find more data on corporate lobbying on Quiver Quantitative.
ALL Congressional Stock Trading
Members of Congress have traded $ALL stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $ALL stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 04/07.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
ALL Insider Trading Activity
ALL insiders have traded $ALL stock on the open market 31 times in the past 6 months. Of those trades, 0 have been purchases and 31 have been sales.
Here’s a breakdown of recent trading of $ALL stock by insiders over the last 6 months:
- THOMAS J WILSON (Chairman, President & CEO) has made 0 purchases and 26 sales selling 332,185 shares for an estimated $67,596,208.
- JESSE E MERTEN (EVP & Chief Financial Officer) has made 0 purchases and 4 sales selling 40,102 shares for an estimated $7,480,244.
- JUDITH A SPRIESER sold 1,300 shares for an estimated $272,145
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ALL Hedge Fund Activity
We have seen 673 institutional investors add shares of ALL stock to their portfolio, and 700 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FRANKLIN RESOURCES INC added 4,310,485 shares (+1746.8%) to their portfolio in Q1 2025, for an estimated $892,572,128
- PRICE T ROWE ASSOCIATES INC /MD/ added 2,374,684 shares (+25.4%) to their portfolio in Q1 2025, for an estimated $491,725,815
- BOSTON PARTNERS added 2,134,893 shares (+613.9%) to their portfolio in Q1 2025, for an estimated $442,072,293
- GAMMA INVESTING LLC removed 1,266,397 shares (-99.4%) from their portfolio in Q2 2025, for an estimated $254,938,380
- MILLENNIUM MANAGEMENT LLC removed 1,263,371 shares (-95.7%) from their portfolio in Q1 2025, for an estimated $261,606,232
- STRATEGIC FINANCIAL CONCEPTS, LLC removed 1,114,760 shares (-99.6%) from their portfolio in Q1 2025, for an estimated $230,833,353
- BANK OF NEW YORK MELLON CORP removed 1,087,755 shares (-31.3%) from their portfolio in Q1 2025, for an estimated $225,241,427
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ALL Analyst Ratings
Wall Street analysts have issued reports on $ALL in the last several months. We have seen 7 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 07/09/2025
- Keefe, Bruyette & Woods issued a "Outperform" rating on 07/09/2025
- William Blair issued a "Sector Outperform" rating on 06/06/2025
- Morgan Stanley issued a "Overweight" rating on 05/06/2025
- Raymond James issued a "Strong Buy" rating on 05/05/2025
- Evercore ISI Group issued a "Outperform" rating on 05/01/2025
- Barclays issued a "Underweight" rating on 04/11/2025
To track analyst ratings and price targets for ALL, check out Quiver Quantitative's $ALL forecast page.
ALL Price Targets
Multiple analysts have issued price targets for $ALL recently. We have seen 8 analysts offer price targets for $ALL in the last 6 months, with a median target of $232.5.
Here are some recent targets:
- Brian Meredith from UBS set a target price of $235.0 on 07/09/2025
- Meyer Shields from Keefe, Bruyette & Woods set a target price of $237.0 on 07/09/2025
- Alex Scott from Barclays set a target price of $188.0 on 07/07/2025
- Bob Huang from Morgan Stanley set a target price of $235.0 on 05/06/2025
- Elyse Greenspan from Wells Fargo set a target price of $197.0 on 05/06/2025
- C. Gregory Peters from Raymond James set a target price of $250.0 on 05/05/2025
- Oliver Wintermantel from Evercore ISI Group set a target price of $230.0 on 05/01/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
